Shanghai Haoyuan Pharmaceutical, 0.2% 28nov2030, CNY (Conv.)
Inländische Anleihen, Variabler Zinssatz, Wandelanleihen
Inländische Anleihen, Variabler Zinssatz, Wandelanleihen
|
Shanghai Haoyuan Pharmaceutical Co., Ltd., established in 2006 and listed on the STAR Market (stock code: 688131), is primarily engaged in providing CRO and CDMO services for small molecule and novel drug modalities to the global ...
Shanghai Haoyuan Pharmaceutical Co., Ltd., established in 2006 and listed on the STAR Market (stock code: 688131), is primarily engaged in providing CRO and CDMO services for small molecule and novel drug modalities to the global pharmaceutical and biotech industry. The company specializes in research, development, and production of pharmaceutical building blocks, intermediates, APIs, and formulations with an integrated service platform covering the entire drug development process.
|
| Step-up/Step-down |
|
|
|
|
|
|
|
|
Entdecken Sie die umfangreichste Datenbank
1 000 000
Anleihen weltweit
80 234
Aktien
167 970
ETF & Funds
80 000
Indizes
Verwalten Sie Ihr Portfolio auf effizienteste Weise